chrisvoncsefalvay/vaers-outcomes huggingface dataset:
0845 flush to chest and throat 0850 vitals checked BP: 90/60 0930 Benadryl 50 mg PO taken 1000 hives to left side of neck 1005 another 50 mg of Benadryl PO taken and Tylenol 650 mg PO for chills and headache 1200 famotidine PO taken for burning to stomach 1400 diarrhea and weakness. Hives had subsided  1800 another round of Benadryl and Tylenol and famotidine.  Saturday at 0200 woke up abruptly itching all over. Took more Benadryl. Saturday all day medicated every six hours with Tylenol, Benadryl and Pepcid. Diarrhea continued with abdominal cramps.  Sunday continued same treatment for same symptoms. Hydration was aggressive and added Bentyl. Monday, Tuesday and Wednesday symptoms continued except for the itchiness. Continued Tylenol. Diarrhea persists as well as body aches, weakness and headaches.  Friday, it is now a week and I still have diarrhea and chills and weakness.
SkinRash Sore arm Narrative:  Redness about the size of a quarter on left hand, sore arm day after injection
I?m not positive if this is related to the vaccine, but I developed a chest cold starting yesterday. Symptoms include post nasal drip, phlegm in the chest, wet cough, and fatigue. While I am not medically diagnosed as immune compromised, immunodeficiency runs in my family and I am frequently sick, I wanted to report just to be safe.
Information has been received on 14-MAY-2018 regarding a case in litigation from a lawyer and a female consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. On or about 04-MAY-2015, the patient was inoculated with ZOSTAVAX vaccine (lot number and expiration unknown) unknown route, at a pharmacy. The inoculation was recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended. On or about 09-MAY-2015, the patient contracted a persistent strain of shingles, or herpes zoster. The patient was treated at a family care center, for the onset of a blistering rash, which was diagnosed as herpes zoster, or shingles.  As a direct and proximate result of the defective ZOSTAVAX, and or as a result of the tenuous efficacy of the vaccine, the patient suffered painful injuries and damages, and required extensive medical care and treatment. Further, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The reporter considered the events to be related to with ZOSTAVAX vaccine. The outcome of the events was unknown. Additional information has been requested.
Gastrointestinal disorder; nervous system disorder; lymphatic system; This is a spontaneous report from a contactable consumer (patient). A 38-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: was not reported), via an unspecified route of administration, administrated in Left arm on 26Jul2021 10:00 (age at the time of vaccination 38-years-old), as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: was not reported), via an unspecified route of administration, administrated in Left arm on 05Jul2021 (age at the time of vaccination 38-years-old), as a single dose for COVID-19 immunization. No other vaccine in four weeks. No other medications in two weeks. No COVID prior vaccination. No known allergies. On 08Aug2021 13:00, the patient experienced Gastrointestinal disorder, nervous system disorder, and lymphatic system. On 18Sep2021, the patient underwent lab tests and procedures which included PCR, SARS-CoV-2 test: Negative, Nasal Swab. Adverse event resulted in emergency room/department or emergency room/department visit. No treatment was received for all adverse events. The outcome for all the events was not recovered.  Follow up (24Sep2021): This is a follow-up spontaneous report received in response to the mail trail sent regarding the confirmation below mentioned query. The response included: translation of the complete attached Agency reports.  The lot number for [BNT162B2], was not provided and will be requested during follow up.
10-29-08 5:00pm R deltoid becomes sore. 9pm R arm becomes tender red, swollen & 3 orange size blotches appear on arm near elbow.  Client takes BENADRYL & TYLENOL.  10-30-08  10-31-08 - Very sore, painful, swollen & fever in arm.  BENADRYL & TYLENOL.  11-1-08 Reduced swelling + pain, 11-2-08 Resolved.
This case was reported by a physician and described the occurrence of fever in an 11 month old male patient who received PEDIARIX vaccine. The patient's past medical history included allergy to rice and allergy to wheat. On 13AUG2003, the patient received the first dose of PEDIARIX. On 13AUG2003, the patient also received an injection of Haemophilus influenzae type b conjugate vaccine. At an unspecified time following the administration of the first dose of PEDIARIX, on 13AUG2003, the patient experienced a fever. the fever resolve don 15AUG2003. On 29APR2004, the patient received the second dose of PEDIARIX. This represents a schedule of eight months between the first and second doses of PEDIARIXx. The recommended interval between the first and second doses of PEDIARIX is six to eight weeks. On 29APR2004, the patient also received an injection of Haemophilus influenzae type b conjugate vaccine. Immediately after the administration of PEDIARIX, on 29APRIL2004, the patient experienced a fever of 102 degrees Fahrenheit and "persistent crying for two to three hours per day." The patient was seen at a physician's office. The fever and crying resolved on 6MAY2004. The immunization series with PEDIARIX was discontinued. On 28JUN2004, the patient received an injection of DTaP as the third dose in the DTaP vaccine series. The following day, on 29JUNE2004, the patient "woke up with the right eye closed and low tone on the right side of the face." The events improved on an unspecified date in 2004, "after a few days.".
Information has been received, for the Pregnancy Registry for GARDASIL (lot number #660393/0067X), from a 15 year old female with a history of anxiety attacks and latent tuberculosis infection (+PPD, negative chest X-ray) and concurrent medical condition of cold who was vaccinated with the second dose of GARDASIL on 30-SEP-2008. Other medication used during this pregnancy included MOTRIN, POLYTRIM, ZOLOFT, SUDAFED and prenatal vitamins (unspecified). It was subsequently learned that the patient was pregnant at the time. Her LMP was 02-SEP-2008. A pregnancy test was performed. On 28-JUL-2008, urine HCG test was negative. On 17-OCT-2008 urine HCG was faint positive and serum HCG was positive (126.7). The patient experienced spontaneous abortion on 22-OCT-2008. The duration from LMP to abortion was more than 7 weeks. The patient sought unspecified medical attention. Follow-up information has been received from a physician who reported that the patient received the second dose of GARDASIL On 30-SEP-2008. It was reported that the patient had history of latent tuberculosis infection and concurrent medical condition of cold. The patient took isoniazid for the treatment of tuberculosis. During this pregnancy the patient took MOTRIN, POLYTRIM drops for the treatment of conjunctivitis, ZOLOFT for the treatment of depression, SUDAFED for the treatment of cold and prenatal vitamins (unspecified). On 22-OCT-2008 the patient experienced spontaneous abortion. Upon internal review, spontaneous abortion was considered to be a other important medical event. Additional information has been requested.
Breakthru COVID-19 infection with symptom onset 6/23/21, infection confirmed by PCR testing
Growing lump around the injection site; Itchiness around the injection site; Redness around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Growing lump around the injection site), INJECTION SITE PRURITUS (Itchiness around the injection site) and INJECTION SITE ERYTHEMA (Redness around the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE MASS (Growing lump around the injection site), INJECTION SITE PRURITUS (Itchiness around the injection site) and INJECTION SITE ERYTHEMA (Redness around the injection site). At the time of the report, VACCINATION SITE MASS (Growing lump around the injection site), INJECTION SITE PRURITUS (Itchiness around the injection site) and INJECTION SITE ERYTHEMA (Redness around the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.  Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
I had the vacine but still got shingles/suspected vaccination failure; I had the vacine but still got shingles; They hurt; They / itch like--; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, pain and pruritus. On an unknown date, the outcome of the vaccination failure, shingles, pain and pruritus were unknown.   It was unknown if the reporter considered the vaccination failure, shingles, pain and pruritus to be related to Shingles vaccine.  Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported but it was captured as adult as per vaccine indication. The patient had the vaccine but still got shingles, they hurt and itch like. Reporter's physician said it would have been a lot worse if he or she had not gotten the vaccine. This case was considered as suspected vaccination failure as details regarding completion of vaccination schedule, time to onset for target disease and laboratory confirmation were unknown at the time of reporting.
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided.  It was reported that there had been no power outages that would have impacted the Moderna vaccine. However, the Healthcare professional reiterates that because her facility was unable to download the digital data logger, they would need to treat this issue as a temperature excursion. The data logger was unable to download for the months of Dec-2021, Jan-2022, and Feb-2022. They were filling out a temperature excursion assessment with the State at this time. It was reported that no adverse reactions were reported by any patients.  No treatment medication was provided.
MIGRAINES; SORE THROAT; SORE LEFT ARM; TIRED; This spontaneous report received from a patient concerned a 30 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 204B21A, and expiry: 11-DEC-2021) dose was not reported, administered on 19-AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On 19-AUG-2021, the patient experienced tired. On 20-AUG-2021, the patient experienced migraines. On 20-AUG-2021, the patient experienced sore throat. On 20-AUG-2021, the patient experienced sore left arm. Treatment medications included: acetylsalicylic acid/caffeine/paracetamol. The action taken with covid-19 vaccine was not applicable. The patient had not recovered from tired, sore throat, migraines, and sore left arm. This report was non-serious.
Not sure exact time vaccine given. Approx 4-5 min after injection my daughter expressed "funny" feeling in head, next felt like she had water in ears - color drained from face - breathing appeared to change - more deliberate. Verbalized not being able to see - RN sought MD to come to room - pt lied down - began to feel better after sev. min - BP dropped but recovered. Everything happened very quickly. Only received GARDASIL vaccine 1st dose.
We went to pharmacy for second COVID-10 P-fizer dose. Around 12:15 PM on 06/23/2021 my son Vaccinated and with in one minute my son have start problem. he feel Dizziness. I hold my son very quickly and close his eyes. During dizziness he also complained his vision is low and with in 15-20 second he complained he can see anything with his open eyes. He can listen my word but he can not see. I check his body and it is cold. Nurse check his body temp and it is normal. After 10 minute rest he is ok . He can see everything and he feel little laziness. This is a full story. He drink water after his dizziness gone. I am still watchin him in case if anything. Thanks.
pt recvd vax & 27DEC93 pt had sore arm & next day had redness @ site 3x4 & fever of 102;
Patient had surgery after receiving 1st dose; Patient hasn't received 2nd dose yet; This spontaneous case was reported by a consumer and describes the occurrence of PROCEDURAL COMPLICATION (Patient had surgery after receiving 1st dose) and PRODUCT DOSE OMISSION ISSUE (Patient hasn't received 2nd dose yet) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunization.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On an unknown date, the patient experienced PROCEDURAL COMPLICATION (Patient had surgery after receiving 1st dose) and PRODUCT DOSE OMISSION ISSUE (Patient hasn't received 2nd dose yet). At the time of the report, PROCEDURAL COMPLICATION (Patient had surgery after receiving 1st dose) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Patient hasn't received 2nd dose yet) had resolved. Surgery details were not provided.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: No new information.
Petechiae rash only on bilateral legs that started approximately four hours after vaccines were given. This child also presented with irritability and very fussy. No treatment was given at this time. Continued monitoring of the child was in place. Rash cleared on 5/9/16.
Dizziness, pulsatile tinnitus, fatigue, lightheadedness Blood pressure is normal
4th vaccine, day one got sore and feverish took Tylenol. Tuesday fever 100 treated with Tylenol arm was extremely tender like it had broken glass in it. By Wednesday there was a huge red rash almost from my shoulder to my elbow  fever 101+ more Tylenol slept all day and night., Thursday was going to show morning pharmacist but was told if it didn?t start to go down that day or the next to sho show the other pharmacist so I went back home fever was back down to 99 taking Tylenol. Throughout the whole time I had no appetite could barely make myself drink and had diarrhea and a headache. Went to my doctors office first thing Friday and saw the NP. He immediately told me it was an allergic reaction and ordered a steroid shot and prescribed 3 days of 20 mg steroids 2x daily an Benadryl at night. I?ve also had a lot of sinus drainage an got Sudafed to help with that. Today?s is Saturday the rash is itching and less tender no fever, the rash is still feverish though.
axillary and groin lymph node - tenderness; groin rash. Pt advised to follow-up with PCP
RN reported that several RN devel red flush; warmth; a fever & erythema at inject site following vax;
Received first dose of shingles vaccine on 7/4. Eight hours later experienced chills, sweating, extreme exhaustion, headaches, muscle and joint pain. Slept 11 hours. Today feel tired and wiped out- unable to get out of bed or perform normal activities.
received her 1st dose of Shingrix, expired; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 50-year-old female patient who received Herpes zoster (Shingrix) (batch number 2Y9R4, expiry date 28th June 2021) for prophylaxis.   On 14th July 2021, the patient received the 1st dose of Shingrix. On 14th July 2021, unknown after receiving Shingrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.  Additional details were provided as follows: The patient received her 1st dose of Shingrix on 14th July2021 but it expired on 28th June 2021, which led to expired vaccine used. No symptoms reported. The reporter consented to follow up.
Hives over the body; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives over the body) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URTICARIA (Hives over the body). At the time of the report, URTICARIA (Hives over the body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided. No relevant concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Follow up received on 14 JUL 2021: Updated Contact information.
SEVERE BILATERAL SENSORINEURAL HEARING LOSS THE NEXT DAY AFTER VACCINATION GIVEN
NauseaVomiting Left eye swelling from 2nd dose. First dose: chest  pain, fatigue Narrative:  Other relevant History:
Hep B pediatric dose given instead of adult dose of Hep B. No adverse effect. 2nd pediatric hep b dose given to patient.
Fainted - after using bathroom, felt light-headed, sat down for a bit, stood up and woke up on floor with scratched, sore nose. Assume I fainted and hit head on door on way to floor. Not sure how long I was out. Probably suffered a mild concussion,
Recvd MMR/HIB # 3 on 16JUL91; Devel fever on 18JUL thru 21JUL on 21JUL broke out w/small red rash; OK p/rash appeared;
I got sick on Wednesday evening and I went to get tested. My son tested positive 10 days ago. My son also had it. I still have COVID. My symptoms feel like a sever cold. I have a cough, I am taking Robitussin for the cough along with Tylenol. I have been testing daily. My nose is runny like a full faucet but I was still negative. I spoke with the nurse from my provider office who had me come in to do the PCR test which I did. I still have a cough and runny nose. Initially my eyes were itchy and red. I still have a little but its not severe as before.
Pain in left arm, gradually lessening, but still active.  Did not seem like a muscular pain.  12/22/2021 ultra sound revealed a non-occulusive blood clot in brachial vein.  High blood pressure also present. Ongoing treatment with Losartan and Xarelto. Currently waiting to see results of ongoing treatment.
Patient noticed redness and swelling that extended down to the elbow the following morning after administration of Boostrix vaccine. He went to nearby urgent care and was diagnosed with cellulitis and was prescribed ampicillin regimen.
Pt developed a 6 x 4 cm erythematous, warm, tender to touch area on left upper lateral thigh. Pt also developed a papular rash on torso. Pt was treated with compresses and Tylenol and was monitored.
Patient given covid shot.  Around an hour after the patient started  having a seizure .  Nurse gave oxygen and called rescue squad.  Patient take to hospital
Information has been received from a registered pharmacist concerning a pt  who was vaccinated in January 2000 and post vaccination she experienced an allergic reaction. Unspecified medical attention was sought. Additional information has been requested.
12/4/03 (4am) sore muscles, rapid pulse with irregular beat then fell back asleep until 130pm woke with fast pulse (100bpm) but no irregular beat currently 4pm (108bpm).
30-minutes after injection, patient developed sub sternal chest pain radiating to back. Sent to ER. Lab tests (Troponin, WBC, Chest x-ray) nl. GI cocktail (antacid, Lidocaine 2% viscous) helped sx.
After trying to inject ZOSTAVAX into the pts arm the needle never pierced the pt's skin and the vaccine leaked onto the pt's skin.
5 x 7cm induration; 13 x 20 cm erythema. Benadryl
Received my second dose of Pfizer on Jan 1, 2021. Was able to easily run 8 miles that same day. About 10 hrs later experienced a headache and body aches that lasted for about 12 hrs and then resolved. The following week I attempted running on Jan 3rd and my recorded pace was much slower and felt much harder. Then I began noticing that it became difficult to walk up one flight of stairs and I would have to stop to catch my breath. This continued for roughly a couple of weeks and slowly improved. I did not seek medical attention as I was one of the first non-trial citizens to be vaccinated and I just attributed the decreased exercise tolerance and shortness of breath as side effects to the vaccine. However, none of my colleagues experienced this to my knowledge. I just received an email from work notifying us that there may be a link to the vaccine and myocarditis or pericarditis, so I thought I would report my symptoms. I did report, but the option for shortness of breath did not exist then.
7:00am hives right arm 11:00am hives spread on left arm  12:30pm hives spread to neck and face under chin and cheeks  1:00pm went to ER